Embracing Future Holdings Ltd
Company Profile
Business description
Embracing Future Holdings Ltd formerly, Biolidics Ltd is engaged in technology development, technology transfer, marketing, sales, and distribution of biomedical technology, life, and medicine science-related products and services, and investment holding. The company's business segments are: Cancer, Infectious Diseases, E-sports, and Corporate. The company generates the majority of its revenue from the E-sports segment, which involves identifying and assessing potential collaboration partners, technology, digital platforms, products, and services related to E-Sports.. Its operations are spread across Singapore, Japan, China, Europe, the United States, Hong Kong, the Philippines, Indonesia, and other countries.
Contact
18 Howard Road
No. 11-09 Novelty BizCentre
Singapore369585
SGPT: +65 64820668
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
7
Stocks News & Analysis
stocks
AI stocks post big gains in Q3. These are the winners and losers
stocks
12 picks for an income portfolio - Q3 2025 update
stocks
ASX’s only dividend aristocrat reports
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,280.00 | 38.90 | -0.42% |
CAC 40 | 7,971.78 | 109.76 | -1.36% |
DAX 40 | 24,378.29 | 0.51 | -0.00% |
Dow JONES (US) | 46,694.97 | 63.31 | -0.14% |
FTSE 100 | 9,479.14 | 12.11 | -0.13% |
HKSE | 26,957.77 | 183.15 | -0.67% |
NASDAQ | 22,941.67 | 161.16 | 0.71% |
Nikkei 225 | 47,944.76 | 2,175.26 | 4.75% |
NZX 50 Index | 13,489.24 | 24.85 | -0.18% |
S&P 500 | 6,740.28 | 24.49 | 0.36% |
S&P/ASX 200 | 8,981.40 | 34.80 | -0.39% |
SSE Composite Index | 3,882.78 | 20.25 | 0.52% |